Cargando…
Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody
BACKGROUND: The HIV-1 Nef protein is essential for AIDS pathogenesis by its interaction with host cell surface receptors and signaling factors. Despite its critical role as a virulence factor Nef is not targeted by current antiviral strategies. RESULTS: We have determined the crystal structure of th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007562/ https://www.ncbi.nlm.nih.gov/pubmed/24620746 http://dx.doi.org/10.1186/1742-4690-11-24 |
_version_ | 1782314350171652096 |
---|---|
author | Lülf, Sebastian Matz, Julie Rouyez, Marie-Christine Järviluoma, Annika Saksela, Kalle Benichou, Serge Geyer, Matthias |
author_facet | Lülf, Sebastian Matz, Julie Rouyez, Marie-Christine Järviluoma, Annika Saksela, Kalle Benichou, Serge Geyer, Matthias |
author_sort | Lülf, Sebastian |
collection | PubMed |
description | BACKGROUND: The HIV-1 Nef protein is essential for AIDS pathogenesis by its interaction with host cell surface receptors and signaling factors. Despite its critical role as a virulence factor Nef is not targeted by current antiviral strategies. RESULTS: We have determined the crystal structure of the complex formed by a camelid single-domain antibody fragment, termed sdAb19, bound to HIV-1 Nef together with a stabilizing SH3 domain. sdAb19 forms a stoichiometric 1:1 complex with Nef and binds to a conformationally conserved surface at the C-terminus of Nef that overlaps with functionally important interaction sites involved in Nef-induced perturbations of signaling and trafficking pathways. The antibody fragment binds Nef with low nanomolar affinity, which could be attenuated to micromolar affinity range by site-directed mutagenesis of key interaction residues in sdAb19. Fusion of the SH3 domain to sdAb19, termed Neffin, leads to a significantly increased affinity for Nef and formation of a stoichiometric 2:2 Nef–Neffin complex. The 19 kDa Neffin protein inhibits all functions of Nef as CD4 and MHC-I downregulation, association with Pak2, and the increase in virus infectivity and replication. CONCLUSIONS: Together, sdAb19 and Neffin thus represent efficient tools for the rational development of antiviral strategies against HIV-1 Nef. |
format | Online Article Text |
id | pubmed-4007562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40075622014-05-03 Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody Lülf, Sebastian Matz, Julie Rouyez, Marie-Christine Järviluoma, Annika Saksela, Kalle Benichou, Serge Geyer, Matthias Retrovirology Research BACKGROUND: The HIV-1 Nef protein is essential for AIDS pathogenesis by its interaction with host cell surface receptors and signaling factors. Despite its critical role as a virulence factor Nef is not targeted by current antiviral strategies. RESULTS: We have determined the crystal structure of the complex formed by a camelid single-domain antibody fragment, termed sdAb19, bound to HIV-1 Nef together with a stabilizing SH3 domain. sdAb19 forms a stoichiometric 1:1 complex with Nef and binds to a conformationally conserved surface at the C-terminus of Nef that overlaps with functionally important interaction sites involved in Nef-induced perturbations of signaling and trafficking pathways. The antibody fragment binds Nef with low nanomolar affinity, which could be attenuated to micromolar affinity range by site-directed mutagenesis of key interaction residues in sdAb19. Fusion of the SH3 domain to sdAb19, termed Neffin, leads to a significantly increased affinity for Nef and formation of a stoichiometric 2:2 Nef–Neffin complex. The 19 kDa Neffin protein inhibits all functions of Nef as CD4 and MHC-I downregulation, association with Pak2, and the increase in virus infectivity and replication. CONCLUSIONS: Together, sdAb19 and Neffin thus represent efficient tools for the rational development of antiviral strategies against HIV-1 Nef. BioMed Central 2014-03-13 /pmc/articles/PMC4007562/ /pubmed/24620746 http://dx.doi.org/10.1186/1742-4690-11-24 Text en Copyright © 2014 Lülf et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lülf, Sebastian Matz, Julie Rouyez, Marie-Christine Järviluoma, Annika Saksela, Kalle Benichou, Serge Geyer, Matthias Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody |
title | Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody |
title_full | Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody |
title_fullStr | Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody |
title_full_unstemmed | Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody |
title_short | Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody |
title_sort | structural basis for the inhibition of hiv-1 nef by a high-affinity binding single-domain antibody |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007562/ https://www.ncbi.nlm.nih.gov/pubmed/24620746 http://dx.doi.org/10.1186/1742-4690-11-24 |
work_keys_str_mv | AT lulfsebastian structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody AT matzjulie structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody AT rouyezmariechristine structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody AT jarviluomaannika structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody AT sakselakalle structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody AT benichouserge structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody AT geyermatthias structuralbasisfortheinhibitionofhiv1nefbyahighaffinitybindingsingledomainantibody |